A cut-off of 4.89 SUVmax measured on the most FDG-avid axillary lymph node in breast cancer patients with the HER2-positive or TN subtype achieved fair diagnostic accuracy with an AUC of 0.82 in predicting axillary response following NST. Here, ERBB2 is linked to breast carcinoma.